Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: To examine whether feature-fusion (FF) method improves single-shot detector's (SSD's) detection of small brain metastases on contrast-enhanced (CE) T1-weighted MRI. METHODS: The study included 234 MRI scans from 234 patients (64.3 years±12.0; 126 men). The ground-truth annotation was performed semiautomatically. SSDs with and without an FF module were developed and trained using 178 scans. The detection performance was evaluated at the SSDs' 50% confidence threshold using sensitivity, positive-predictive value (PPV), and the false-positive (FP) per scan with the remaining 56 scans. RESULTS: FF-SSD achieved an overall sensitivity of 86.0% (95% confidence interval [CI]: [83.0%, 85.6%]; 196/228) and 46.8% PPV (95% CI: [42.0%, 46.3%]; 196/434), with 4.3 FP (95% CI: [4.3, 4.9]). Lesions smaller than 3 mm had 45.8% sensitivity (95% CI: [36.1%, 45.5%]; 22/48) with 2.0 FP (95% CI: [1.9, 2.1]). Lesions measuring 3-6 mm had 92.3% sensitivity (95% CI: [86.5%, 92.0%]; 48/52) with 1.8 FP (95% CI: [1.7, 2.2]). Lesions larger than 6 mm had 98.4% sensitivity (95% CI: [97.8%, 99.4%]; 126/128) 0.5 FP (95% CI: [0.5, 0.8]) per scan. FF-SSD had a significantly higher sensitivity for lesions < 3 mm (p = 0.008, t = 3.53) than the baseline SSD, while the overall PPV was similar (p = 0.06, t = -2.16). A similar trend was observed even when the detector's confidence threshold was varied as low as 0.2, for which the FF-SSD's sensitivity was 91.2% and the FP was 9.5. CONCLUSIONS: The FF-SSD algorithm identified brain metastases on CE T1-weighted MRI with high accuracy.
No takes yet. Share an insight, caveat, or question.
Amemiya et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: